Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation

被引:65
作者
Sylvester, AM
Chen, DF
Krasinski, K
Andrés, V
机构
[1] Tufts Univ, Div Cardiovasc Res, St Elizabeths Med Ctr, Sch Med,Dept Med Cardiol, Boston, MA 02135 USA
[2] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Biomed Res, Boston, MA 02135 USA
[3] CSIC, Inst Biomed, Valencia 46010, Spain
关键词
vascular smooth muscle cell proliferation; cyclin A; Ras; c-fos; E2F;
D O I
10.1172/JCI1630
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Excessive proliferation of vascular smooth muscle cells (VSMCs) contributes to vessel renarrowing after angioplasty, Here we investigated the transcriptional regulation of the cyclin A gene, a key positive regulator of S phase that is induced after angioplasty, We show that Ras-dependent mitogenic signaling is essential for the normal stimulation of cyclin A promoter activity and DNA synthesis in VSMCs. Overexpression of the AP-1 transcription factor c-fos can circumvent this requirement via interaction with the cAMP-responsive element (CRE) in the cyclin A promoter, Moreover, c-fos overexpression in serum-starved VSMCs results in the induction of cyclin A promoter activity in a CRE-dependent manner, and increased binding of endogenous c-fos protein to the cyclin A CRE precedes the onset of DNA replication in VSMCs induced by serum in vitro and by angioplasty in vivo. We also show that E2F function is essential for both serum-and c-fos-dependent induction of cyclin A expression, Taken together, these findings suggest that c-fos and E2F are important components of the signaling cascade that link Ras activity to cyclin A transcription in VSMCs. These studies illustrate a novel link between the transcriptional and cell cycle machinery that may he relevant to the pathogenesis of vascular proliferative disorders.
引用
收藏
页码:940 / 948
页数:9
相关论文
共 76 条
[1]   SUPPRESSION OF NEOINTIMAL SMOOTH-MUSCLE CELL ACCUMULATION IN-VIVO BY ANTISENSE CDC2 AND CDK2 OLIGONUCLEOTIDES IN RAT CAROTID-ARTERY [J].
ABE, J ;
ZHOU, W ;
TAGUCHI, J ;
TAKUWA, N ;
MIKI, K ;
OKAZAKI, H ;
KUROKAWA, K ;
KUMADA, M ;
TAKUWA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) :16-24
[2]   TRANSCRIPTIONAL CONTROL BY E2F [J].
ADAMS, PD ;
KAELIN, WG .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (02) :99-108
[3]   Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1) [J].
Aktas, H ;
Cai, H ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) :3850-3857
[4]   TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS [J].
ALBANESE, C ;
JOHNSON, J ;
WATANABE, G ;
EKLUND, N ;
VU, D ;
ARNOLD, A ;
PESTELL, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23589-23597
[5]  
ANDRES V, 1995, MOL CELL BIOL, V15, P4272
[6]   Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis [J].
Andres, V ;
Walsh, K .
JOURNAL OF CELL BIOLOGY, 1996, 132 (04) :657-666
[7]   INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO AND IN-VIVO BY C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
BENNETT, MR ;
ANGLIN, S ;
MCEWAN, JR ;
JAGOE, R ;
NEWBY, AC ;
EVAN, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :820-828
[8]   ADENOVIRUS-MEDIATED OVER-EXPRESSION OF THE CYCLIN CYCLIN-DEPENDENT KINASE INHIBITOR, P21 INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION IN THE RAT CAROTID-ARTERY MODEL OF BALLOON ANGIOPLASTY [J].
CHANG, MW ;
BARR, E ;
LU, MM ;
BARTON, K ;
LEIDEN, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2260-2268
[9]   CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT [J].
CHANG, MW ;
BARR, E ;
SELTZER, J ;
JIANG, YQ ;
NABEL, GJ ;
NABEL, EG ;
PARMACEK, MS ;
LEIDEN, JM .
SCIENCE, 1995, 267 (5197) :518-522
[10]   Downregulation of cyclin-dependent kinase 2 activity and cyclin a promoter activity in vascular smooth muscle cells by p27(KIP1), inhibitor of neointima formation in the rat carotid artery [J].
Chen, DH ;
Krasinski, K ;
Chen, DF ;
Sylvester, A ;
Chen, J ;
Nisen, PD ;
Andres, V .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2334-2341